Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Main research areas

EATING DISORDERS Psychological and Biological aspects

Employment

Research Associate Professor, Senior Consultant Psychiatrist

Ledende overlæge dr. med.

Mental Health Centre Ballerup

The Capital Region of Denmark

1 Feb 2015 → present

Psykiatrisk Center Ballerup

Ledende overlæge dr. med.

Mental Health Centre Ballerup

The Capital Region of Denmark

1 Mar 2014 → present

Associate Professor

Department of Clinical Neuroscience, Neurosurgery, University of Gothenburg, Sahlgrenska Academy, Sahlgrenska University Hospital, Gothenburg, Sweden.

1 Jun 2002 → …

Research outputs

Explanatory Factors for Disease-Specific Health-Related Quality of Life in Women with Anorexia Nervosa

Winkler, L. A-D., Gudex, C., Lichtenstein, M. B., Røder, M. E., Adair, C. E., Sjögren, J. M. & Støving, R. K., 9 Apr 2021, In: Journal of Clinical Medicine. 10, 8, 1592.

Cognitive function in adults with enduring anorexia nervosa

Seidel, M., Brooker, H., Lauenborg, K., Wesnes, K. & Sjögren, M., Mar 2021, In: Nutrients. 13, 3, p. 1-11 11 p., 859.

Weight gain in adults with avoidant/restrictive food intake disorder compared to restrictive anorexia nervosa—pilot findings from a longitudinal study

Fjeldstad, M., Kvist, T. & Sjögren, M., Mar 2021, In: Nutrients. 13, 3, p. 1-9 9 p., 871.

A Systematic Review and Meta-Analysis Finds Increased Blood Levels of All Forms of Ghrelin in Both Restricting and Binge-Eating/Purging Subtypes of Anorexia Nervosa

Seidel, M., Markmann Jensen, S., Healy, D., Dureja, A., Watson, H. J., Holst, B., Bulik, C. M. & Sjögren, J. M., 23 Feb 2021, In: Nutrients. 13, 2, p. 1-19 19 p., 709.

Comorbid depression as a negative predictor of weight gain during treatment of anorexia nervosa: A systematic scoping review

Eskild-Jensen, M., Støving, R. K., Flindt, C. F. & Sjogren, M., Nov 2020, In: European Eating Disorders Review. 28, 6, p. 605-619 15 p.

Study protocol of comprehensive risk evaluation for anorexia nervosa in twins (CREAT): a study of discordant monozygotic twins with anorexia nervosa

Seidel, M., Ehrlich, S., Breithaupt, L., Welch, E., Wiklund, C., Hübel, C., Thornton, L. M., Savva, A., Fundin, B. T., Pege, J., Billger, A., Abbaspour, A., Schaefer, M., Boehm, I., Zvrskovec, J., Rosager, E. V., Hasselbalch, K. C., Leppä, V., Sjögren, M., Nergårdh, R., Feusner, J. D., Ghaderi, A. & Bulik, C. M., 14 Oct 2020, In: BMC Psychiatry. 20, 1, p. 507

Cognitive improvement following weight gain in patients with anorexia nervosa: A systematic review

Hemmingsen, S. D., Wesselhoeft, R., Lichtenstein, M. B., Sjögren, J. M. & Støving, R. K., 12 Oct 2020, (E-pub ahead of print) In: European Eating Disorders Review.

Potential shortcomings in current studies on the effect of intranasal oxytocin in Anorexia Nervosa and healthy controls - A systematic review and meta-analysis

Hasselbalch, K. C., Lanng, K. R., Birkeland, M. & Sjögren, M., Oct 2020, In: Psychopharmacology. 237, 10, p. 2891-2903 13 p.

Sexual function and dysfunction among women with anorexia nervosa: A systematic scoping review

Price, T., Zebitz, M., Giraldi, A., Lokind, T. S., Treasure, J. & Sjögren, J. M., Sep 2020, In: International Journal of Eating Disorders. 53, 9, p. 1377-1399 23 p.

Case report: cognitive performance in an extreme case of anorexia nervosa with a body mass index of 7.7

Hemmingsen, S. D., Lichtenstein, M. B., Hussain, A. A., Sjögren, J. M. & Støving, R. K., 5 Jun 2020, In: BMC Psychiatry. 20, 1, p. 284 12 p., 284.

Slime-loving bacteria from fresh faeces may be able to help anorexia patients

Barfod, K. K. & Sjögren, J. M., 5 May 2020, In: ScienceNordic.

Treatment studies with cannabinoids in anorexia nervosa - a systematic review

Rosager, E. V., Møller, C. & Sjögren, M., 2 Apr 2020, (E-pub ahead of print) In: Eating and Weight Disorders.

Hvorfor fravælger halvdelen behandling for en spiseforstyrrelse?

Sjögren, J. M., Gildberg, F. A. & Thor Andersen, S., 2020, In: LMS.

A systematic review of blood-based serotonergic biomarker in Bulimia Nervosa

Sjögren, J. M., Nielsen, A. S. M., Hasselbalch, K. C., Wøllo, M. & Hansen, J. S., Sep 2019, In: Psychiatry Research. 279, p. 155-171 17 p.

Increased lipid and lipoprotein concentrations in anorexia nervosa: A systematic review and meta-analysis

Hussain, A. A., Hübel, C., Hindborg, M., Lindkvist, E., Kastrup, A. M., Yilmaz, Z., Støving, R. K., Bulik, C. M. & Sjögren, J. M., Jun 2019, In: International Journal of Eating Disorders. 52, 6, p. 611-629 19 p.

Spiseforstyrrelser i en digital tidsalder

Sjögren, J. M. & Bentz, M., 5 Apr 2019

Slim-elskende bakterier fra frisk lort kan måske hjælpe anoreksi-patienter

Sjögren, J. M. & Barfod, K. K., 2 Apr 2019, In: videnskab.dk.

Dysbiosis of the Microbiota in Anorexia Nervosa: Pathophysiological Implications

Sjögren, J. M., Frostad, S. & Barfod, K. K., 18 Mar 2019, Anorexia and Bulimia Nervosa . London, UK: InTech Open Access Publisher

Stressfraktur i bilateral rami hos en kvinde med anorexia nervosa

Bashir, K., Sjögren, M. & Klit, J., 18 Mar 2019, In: Ugeskrift for Laeger. 181, 12, V10180702.

The Diagnostic Work-Up of Body Dysmorphic Disorder

Sjögren, J. M., 1 Jan 2019, In: EC Psychology and Psychiatry. 8, 1, p. 72-76 5 p.

NBV: Anorexia nervosa og andre spiseforstyrrelser

Støving, R. K., Solis, A. B., Richelsen, B., Feltoft, C. L., Frølich, J., Ibsen, J. R., Winkler, L. A-D., Sjögren, J. M., Poulsen, M. M. & Holmager, P., 2019, Dansk Endokrinologisk Selskab

Reernæringssyndrom ved anorexia nervosa

Ibrahim, I. B., Hussain, A. A. & Sjögren, J. M., 30 Apr 2018, In: Ugeskrift for Laeger. 180, 18, p. 2-6 5 p., V06170463.

Forsker: 'Jo længere man har haft anoreksi, jo sværere er det at komme sig helt’

Sjögren, J. M., 11 Apr 2018, In: BT. 4/11/2018, 2 p.

Anorexia nervosa, bulimia nervosa, og binge eating disorder (F50)

Sjögren, J. M. & Rosenberg, R., 10 Jan 2018, Klinisk neuropsykiatri - fra molekyle til sygdom. Videbech, P. & Rosenberg, R. (eds.). p. 459-475 26 p.

A systematic review of studies on the faecal microbiota in anorexia nervosa: future research may need to include microbiota from the small intestine

Schwensen, H. F., Kan, C., Treasure, J., Høiby, N. & Sjögren, M., 2018, In: Eating and Weight Disorders. 23, 4, p. 399-418 19 p.

Forløbsprogram for børn og unge med spiseforstyrrelse

Sjögren, J. M., Dec 2017, 51 p.

Body dysmorphic disorder

Jawad, M. B. M. & Sjögren, M., 1 Mar 2017, In: Ugeskrift for Laeger. 179, 9, p. 776-779 4 p., 9.

Biomarkers for anorexia nervosa

Sjøgren, J. M., 16 Jan 2017, In: Ugeskrift for Laeger. 179, 3, p. 431-434 4 p., 5.

An update on genetic and serotoneric biomarker findings in Bulimia Nervosa

Sjögren, J. M., 2017, In: EC Neurology. 7, 3, p. 107-116 10 p.

Spiseforstyrrelser.

Sjögren, J. M. & Rosenberg, R., 2017, Klinisk neuropsykiatri : Fra molekyle til sygdom. Videbech, P. & Rosenberg, R. (eds.). FADL's forlag, p. 459-475 17 p.

An integrated multi-study analysis of intra-subject variability in cerebrospinal fluid amyloid-β concentrations collected by lumbar puncture and indwelling lumbar catheter

Lucey, B. P., Gonzales, C., Das, U., Li, J., Siemers, E. R., Slemmon, J. R., Bateman, R. J., Huang, Y., Fox, G. B., Claassen, J. A. H. R., Slats, D., Verbeek, M. M., Tong, G., Soares, H., Savage, M. J., Kennedy, M., Forman, M., Sjögren, M., Margolin, R., Chen, X., Farlow, M. R., Dean, R. A. & Waring, J. F., 29 Jul 2015, In: Alzheimer's research & therapy. 7, 1, p. 53

Effect of diagnostic criteria on prevalence of frontotemporal dementia in the elderly

Gislason, T. B., Östling, S., Börjesson-Hanson, A., Sjögren, M., Simoni, M., Pantoni, L. & Skoog, I., Apr 2015, In: Alzheimer's & dementia : the journal of the Alzheimer's Association. 11, 4, p. 425-33 9 p.

A randomised trial of the effect of the glycine reuptake inhibitor Org 25935 on cognitive performance in healthy male volunteers

Christmas, D., Diaper, A., Wilson, S., Rich, A., Phillips, S., Udo de Haes, J., Sjogren, M. & Nutt, D., Mar 2014, In: Human Psychopharmacology. 29, 2, p. 163-71 9 p.

Alzheimer biomarkers and clinical Alzheimer disease were not associated with increased cerebrovascular disease in a memory clinic population

Spies, P. E., Verbeek, M. M., Sjögren, J. M., de Leeuw, F-E. & Claassen, J. A. H. R., Jan 2014, In: Current Alzheimer Research. 11, 1, p. 40-6 7 p.

Developing novel blood-based biomarkers for Alzheimer's disease

Snyder, H. M., Carrillo, M. C., Grodstein, F., Henriksen, K., Jeromin, A., Lovestone, S., Mielke, M. M., O'Bryant, S., Sarasa, M., Sjøgren, M., Soares, H., Teeling, J., Trushina, E., Ward, M., West, T., Bain, L. J., Shineman, D. W., Weiner, M. & Fillit, H. M., Jan 2014, In: Alzheimer's & dementia : the journal of the Alzheimer's Association. 10, 1, p. 109-114 6 p.

The future of blood-based biomarkers for Alzheimer's disease

Henriksen, K., O'Bryant, S. E., Hampel, H., Trojanowski, J. Q., Montine, T. J., Jeromin, A., Blennow, K., Lönneborg, A., Wyss-Coray, T., Soares, H., Bazenet, C., Sjögren, J. M., Hu, W., Lovestone, S., Karsdal, M. A. & Weiner, M. W., Jan 2014, In: Alzheimer's and Dementia. 10, 1, p. 115-131 17 p.

Blood based gene expression: Useful biomarkers for Alzheimer's and Parkinson's diseases

Lönneborg, A., Røed, L. & Sjögren, M., 1 Dec 2013, Recent Trends in Gene Expression. Nova Science Publishers, Inc, p. 191-208 18 p.

Prediction of mild cognitive impairment that evolves into Alzheimer's disease dementia within two years using a gene expression signature in blood: a pilot study

Roed, L., Grave, G., Lindahl, T., Rian, E., Horndalsveen, P. O., Lannfelt, L., Nilsson, C., Swenson, F., Lönneborg, A., Sharma, P. & Sjögren, M., 2013, In: Journal of Alzheimer's disease : JAD. 35, 3, p. 611-21 11 p.

Hourly variability of cerebrospinal fluid biomarkers in Alzheimer's disease subjects and healthy older volunteers

Slats, D., Claassen, J. A. H. R., Spies, P. E., Borm, G., Besse, K. T. C., van Aalst, W., Tseng, J., Sjögren, M. J. C., Olde Rikkert, M. G. M. & Verbeek, M. M., Apr 2012, In: Neurobiology of Aging. 33, 4, p. 831.e1-9

Glycine transporter inhibitor attenuates the psychotomimetic effects of ketamine in healthy males: preliminary evidence

D'Souza, D. C., Singh, N., Elander, J., Carbuto, M., Pittman, B., Udo de Haes, J., Sjogren, M., Peeters, P., Ranganathan, M. & Schipper, J., Mar 2012, In: Neuropsychopharmacology. 37, 4, p. 1036-46 11 p.

Evaluation of the glycine transporter inhibitor Org 25935 as augmentation to cognitive-behavioral therapy for panic disorder: a multicenter, randomized, double-blind, placebo-controlled trial

Nations, KR., Smits, JA., Tolin, DF., Rothbaum, BO., Hofmann, SG., Tart, CD., Lee, A., Schipper, J., Sjogren, M. & Xue, D., 2012, In: The Journal of Clinical Psychiatry. 73, 5, p. 647-653 7 p.

Alzheimer's disease and cerebrovascular disease: Related or coexisting?

Spies, P. E., Verbeek, M., Olde Rikkert, M., Claassen, J. A. H. R. & Sjögren, J. M., 2011, In: Alzheimer's & Dementia. 7, 4, p. 146-7

Evidence based practice in complex diagnostics and therapeutics in dementia.

OldeRikkert, M., Verbeek, M. & Sjogren, M., 2011, Dementia Symposium. p. 139-144 6 p.

Secular changes in cognitive predictors of dementia and mortality in 70-year-olds

Sacuiu, S., Gustafson, D., Sjögren, M., Guo, X., Ostling, S., Johansson, B. & Skoog, I., 31 Aug 2010, In: Neurology. 75, 9, p. 779-85 7 p.

The cerebrospinal fluid amyloid beta42/40 ratio in the differentiation of Alzheimer's disease from non-Alzheimer's dementia

Spies, P. E., Slats, D., Sjögren, M., Kremer, B. P. H., Verhey, F. R. J., Rikkert, M. G. M. O. & Verbeek, M. M., Aug 2010, In: Current Alzheimer Research. 7, 5, p. 470-6 7 p.

Apathy is a prominent neuropsychiatric feature of radiological white-matter changes in patients with dementia

Jonsson, M., Edman, A., Lind, K., Rolstad, S., Sjögren, M. & Wallin, A., Jun 2010, In: International Journal of Geriatric Psychiatry. 25, 6, p. 588-95 8 p.

Cerebrospinal Fluid Biomarkers in Diagnosing Alzheimer's Disease in Clinical Practice: An Illustration with 3 Case Reports

Slats, D., Spies, P. E., Sjögren, M. J. C., Verhey, F. R. J., Verbeek, M. M. & Olde Rikkert, M. G. M., 24 Feb 2010, In: Case Reports in Neurology. 2, 1, p. 5-11 7 p.

CSF biomarker utilisation and ethical considerations of biomarker assisted diagnosis and research in dementia: perspectives from within the European Alzheimer's Disease Consortium (EADC)

Slats, D., Spies, P. E., Sjögren, M., Visser, P-J., Verbeek, M. M., Rikkert, M. G. M. O. & Kehoe, P. G., Jan 2010, In: Journal of neurology, neurosurgery, and psychiatry. 81, 1, p. 124-5 2 p.

Hourly variability of cerebrospinal fluid biomarkers in Alzheimer patients and healthy elderly controls

Slats, D., Spies, P. E., Claassen, J. AHR., Sjögren, M. JC., Tseng, J., Verbeek, M. M. & Rikkert, M. GM. O., 2010, In: Alzheimer's & Dementia. 6, 4, p. S131

Informed consent in dementia research. Legislation, theoretical concepts and how to assess capacity to consent

Meulenbroek, O., Vernooij-Dassen, MJFJ., Kessels, RPC., Graff, MJL., Sjögren, MJC., Schalk, BWM., Hoogsteen-Ossewaarde, ME., Claassen, JAHR., Melis, RJF. & Rikkert, MGM. O., 2010, In: European Geriatric Medicine. 1, 1, p. 58-63 6 p.

The use of indexes in the interpretation of cerebrospinal fluid analyses.

Verbeek, M. M. & Sjögren, J. M. C., 2010, In: Neurobiology of Aging. 31, 9, p. 1654; discussion 1655 1 p.

The pattern of cognitive symptoms predicts time to dementia onset

Sacuiu, S., Gustafson, D., Johansson, B., Thorvaldsson, V., Berg, S., Sjögren, M., Guo, X., Ostling, S. & Skoog, I., May 2009, In: Alzheimer's & dementia : the journal of the Alzheimer's Association. 5, 3, p. 199-206 8 p.

Alzheimer hastali\ginda nörofibriler dejenerasyon: moleküler mekanizmalardan ilaç hedeflerinin tanimlanmasina

Pei, J-J., Sjögren, M. & Winblad, B., 2009, In: Current Opinion in Psychiatry. 5, 1, p. 7-14 8 p.

Cerebrospinal fluid alpha-synuclein does not discriminate between dementia disorders

Spies, P. E., Melis, R. J. F., Sjögren, M. J. C., Rikkert, M. G. M. O. & Verbeek, M. M., 2009, In: Journal of Alzheimer's disease : JAD. 16, 2, p. 363-9 7 p.

Cerebrospinal fluid amyloid beta 40 and the amyloid beta 42/40 ratio in differentiating Alzheimer's disease from other dementias

Spies, P., Slats, D., Sjögren, M., Kremer, B., Verhey, F., Rikkert, M. O. & Verbeek, M., 2009, In: Alzheimer's & Dementia. 5, 4, p. P341-P342

Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets

Pei, J-J., Sjögren, M. & Winblad, B., Nov 2008, In: Current Opinion in Psychiatry. 21, 6, p. 555-61 7 p.

Handen ineen voor nader onderzoek: Nieuw licht nodig op risico's dementie

Sjögren, M. & Rikkert, M. O., 3 Oct 2008, In: Pharmaceutisch Weekblad. 143, 40, p. 40-43 4 p.

Structural and quantitative comparison of cerebrospinal fluid glycoproteins in Alzheimer's disease patients and healthy individuals

Sihlbom, C., Davidsson, P., Sjögren, M., Wahlund, L-O. & Nilsson, C. L., Jul 2008, In: Neurochemical Research. 33, 7, p. 1332-40 9 p.

Small heat shock proteins Hsp27 or alphaB-crystallin and the protein components of neurofibrillary tangles: tau and neurofilaments

Björkdahl, C., Sjögren, M. J., Zhou, X., Concha, H., Avila, J., Winblad, B. & Pei, J-J., 1 May 2008, In: Journal of Neuroscience Research. 86, 6, p. 1343-52 10 p.

De praktische betekenis van bewezen risicofactoren voor de ziekte van Alzheimer

Sjogren, M. & Olde-Rikkert, M., 2008, In: Medische Schrijft Nederlands.

Forlenza, Orestes V; Chiu, Edmond

Blumberger, D. M., Daskalakis, Z. J., Mulsant, B. H., Heok, K. E., Ho, R., Suh, G-H., Han, C., Flicker, L., Pei, J-J. & Sjögren, M., 2008, In: Current Opinion in Psychiatry. 21, 6, p. 529-532 4 p.

Assessments of the accumulation severities of amyloid beta-protein and hyperphosphorylated tau in the medial temporal cortex of control and Alzheimer's brains

Zhou, X-W., Li, X., Bjorkdahl, C., Sjogren, M. J., Alafuzoff, I., Soininen, H., Grundke-Iqbal, I., Iqbal, K., Winblad, B. & Pei, J-J., Jun 2006, In: Neurobiology of Disease. 22, 3, p. 657-68 12 p.

Low serum potassium in mid life associated with decreased cerebrospinal fluid Abeta42 in late life

Mielke, M. M., Zandi, P. P., Blennow, K., Gustafson, D., Sjögren, M., Rosengren, L. & Skoog, I., 24 Feb 2006, In: Alzheimer Disease and Associated Disorders. 20, 1, p. 30-6 7 p.

Cholesterol and Alzheimer's disease--is there a relation?

Sjögren, M., Mielke, M., Gustafson, D., Zandi, P. & Skoog, I., Feb 2006, In: Mechanisms of Ageing and Development. 127, 2, p. 138-47 10 p.

Depressive symptoms and white matter changes in patients with dementia

Lind, K., Jonsson, M., Karlsson, I., Sjögren, M., Wallin, A. & Edman, A., Feb 2006, In: International Journal of Geriatric Psychiatry. 21, 2, p. 119-25 7 p.

Frontotemporal dementia--a brief review

Sjögren, M. & Andersen, C., Feb 2006, In: Mechanisms of Ageing and Development. 127, 2, p. 180-7 8 p.

Proteome studies of CSF in AD patients

Davidsson, P. & Sjögren, M., Feb 2006, In: Mechanisms of Ageing and Development. 127, 2, p. 133-7 5 p.

Vagus nerve stimulation in patients with Alzheimer's disease: Additional follow-up results of a pilot study through 1 year

Merrill, C. A., Jonsson, M. A. G., Minthon, L., Ejnell, H., Silander, H. C. S., Blennow, K., Karlsson, M., Nordlund, A., Rolstad, S., Warkentin, S., Ben-Menachem, E. & Sjögren, M. J. C., 1 Jan 2006, In: Journal of Clinical Psychiatry. 67, 8, p. 1171-1178 8 p.

Sammanfattning av SBU: s rapport: Demenssjukdomar-En systematisk litteraturöversikt

Edhag, O., Håkansson, I., Norlund, A., Brorsson, B., Englund, E., Gustafson, L., Londos, E., Sjögren, M., Wallin, A. & Årsland, D., 2006, In: Demenssjukdomar. En systematisk litteraturöversikt. SBU-Statens beredning för medicinsk utvärdering. Stockholm, mars 2006.

Prodromal cognitive signs of dementia in 85-year-olds using four sources of information

Sacuiu, S., Sjögren, M., Johansson, B., Gustafson, D. & Skoog, I., 27 Dec 2005, In: Neurology. 65, 12, p. 1894-900 7 p.

The Goteborg MCI study: mild cognitive impairment is a heterogeneous condition

Nordlund, A., Rolstad, S., Hellström, P., Sjögren, M., Hansen, S. & Wallin, A., Nov 2005, In: Journal of neurology, neurosurgery, and psychiatry. 76, 11, p. 1485-90 6 p.

The need for a consensus in the use of assessment tools for Alzheimer's disease: The feasibility study (assessment tools for dementia in Alzheimer centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey

Ramirez Diaz, S. P., Gregório, P. G., Ribera Casado, J. M., Reynish, E., Ousset, P. J., Vellas, B., Salmon, E., Blesa, R., Boada, M., Bullock, R., Burns, A., Camus, V., Costa-Tsolaki, M., Dartigues, J. F., Erkinjuntti, T., Frisonni, G., Frolich, L., Gomez Isla, T., Hock, C., Jones, R., Kurz, A., Lovestone, S., McKeith, I., Michel, J. P., Olde-Rikkert, M. G. M., Pasquier, F., Rigaud, A. S., Robert, P., Rodriguez, G., Rossor, M., Salva, A., Scheltens, P., Sinclair, A., Sjögren, M., Spiru, L., Thompson, C., Touchon, J., Verhey, F., Waldemar, G. & Winblad, B., 1 Aug 2005, In: International Journal of Geriatric Psychiatry. 20, 8, p. 744-748 5 p.

High total cholesterol levels in late life associated with a reduced risk of dementia

Mielke, M. M., Zandi, P. P., Sjögren, M., Gustafson, D., Ostling, S., Steen, B. & Skoog, I., 24 May 2005, In: Neurology. 64, 10, p. 1689-95 7 p.

Zinc induces neurofilament phosphorylation independent of p70 S6 kinase in N2a cells

Björkdahl, C., Sjögren, M. J., Winblad, B. & Pei, J-J., 25 Apr 2005, In: NeuroReport. 16, 6, p. 591-5 5 p.

Minderung des Demenzrisikos durch hohe Cholesterinspiegel im höheren Lebensalter

Mielke, MM., Zandi, PP. & Sjögren, M., 2005, In: Stroke. 36, p. 731-6

Prodromal cognitive signs of dementia in 85 year-olds-validity of four sources of information in a three year follow-up

Sacuiu, S., Sjögren, M., Johansson, B. & Skoog, I., 2005, In: Alzheimer's & Dementia. 1, 1, p. S19

The effect of simvastatin treatment on the amyloid precursor protein and brain cholesterol metabolism in patients with Alzheimer's disease

Hoglund, K., Thelen, K. M., Syversen, S., Sjogren, M., von Bergmann, K., Wallin, A., Vanmechelen, E., Vanderstichele, H., Lutjohann, D. & Blennow, K., 2005, In: Dementia and Geriatric Cognitive Disorders. 19, 5-6, p. 256-65 10 p.

The link between cholesterol and Alzheimer's disease

Sjögren, M. & Blennow, K., 2005, In: The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry. 6, 2, p. 85-97 13 p.

The use of proteomics in biomarker discovery in neurodegenerative diseases

Davidsson, P. & Sjögren, M., 2005, In: Disease Markers. 21, 2, p. 81-92 12 p.

HPA axis activation determined by the CRH challenge test in patients with few versus multiple episodes of treatment-refractory depression

Ehnvall, A., Sjögren, M., Zachrisson, O. C. & Agren, H., Dec 2004, In: Archiv fur Psychiatrie und Nervenkrankheiten. 254, 6, p. 349-55 7 p.

Validation of a prefractionation method followed by two-dimensional electrophoresis - Applied to cerebrospinal fluid proteins from frontotemporal dementia patients

Hansson, S. F., Puchades, M., Blennow, K., Sjögren, M. & Davidsson, P., 18 Nov 2004, In: Proteome Science. 2, 1, p. 7

Increased intrathecal inflammatory activity in frontotemporal dementia: pathophysiological implications

Sjögren, M., Folkesson, S., Blennow, K. & Tarkowski, E., Aug 2004, In: Journal of neurology, neurosurgery, and psychiatry. 75, 8, p. 1107-11 5 p.

Altered kallikrein 7 and 10 concentrations in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia

Diamandis, E. P., Scorilas, A., Kishi, T., Blennow, K., Luo, L-Y., Soosaipillai, A., Rademaker, A. W. & Sjogren, M., Mar 2004, In: Clinical Biochemistry. 37, 3, p. 230-7 8 p.

Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism

Heilig, M., Zachrisson, O., Thorsell, A., Ehnvall, A., Mottagui-Tabar, S., Sjögren, M., Asberg, M., Ekman, R., Wahlestedt, C. & Agren, H., 6 Feb 2004, In: Journal of Psychiatric Research. 38, 2, p. 113-21 9 p.

Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study

Hampel, H., Buerger, K., Zinkowski, R., Teipel, S. J., Goernitz, A., Andreasen, N., Sjoegren, M., DeBernardis, J., Kerkman, D., Ishiguro, K., Ohno, H., Vanmechelen, E., Vanderstichele, H., McCulloch, C., Moller, H-J., Davies, P. & Blennow, K., Jan 2004, In: Archives of General Psychiatry. 61, 1, p. 95-102 8 p.

Cognitive deficits are detectable in prodromal stages of both Alzheimer's and vascular dementia—A10-year follow up in the population study of women in Gothenburg

Sacuiu, S. F., Sjögren, M. & Skoog, I., 2004, In: Neurobiology of Aging. 25, p. S485

Five-year outcome of cholinergic treatment of Alzheimer's disease: early response predicts prolonged time until nursing home placement, but does not alter life expectancy

Wallin, A. K., Gustafson, L., Sjögren, M., Wattmo, C. & Minthon, L., 2004, In: Dementia and Geriatric Cognitive Disorders. 18, 2, p. 197-206 10 p.

Negative neurofilament light and tau immunostaining in frontotemporal dementia

Sjögren, M. & Englund, E., 2004, In: Dementia and Geriatric Cognitive Disorders. 17, 4, p. 346-9 4 p.

Proteomics for drug target discovery

Gottfries, J., Sjögren, M., Holmberg, B., Rosengren, L., Davidsson, P. & Blennow, K., 2004, In: Chemometrics and Intelligent Laboratory Systems. 73, 1, p. 47-53 7 p.

Vascular factors and Alzheimer’s disease

Skoog, I., Gustafson, D. & Sjögren, M., 2004, In: Alzheimer's Disease and Related Disorders Annual 2004. Gauthier, Cummings, Scheltens, ed.

CSF markers for Alzheimer's disease: total tau, phospho-tau and Abeta42

Andreasen, N., Sjögren, M. & Blennow, K., Oct 2003, In: The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry. 4, 4, p. 147-55 9 p.

CSF Markers for Alzheimer's Disease: Total Tau, Phospho-Tau and Aβ42

Andreasen, N., Sjögren, M. & Blennow, K., Oct 2003, In: World Journal of Biological Psychiatry. 4, 4, p. 147-155 9 p.

Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients

Olsson, A., Höglund, K., Sjögren, M., Andreasen, N., Minthon, L., Lannfelt, L., Buerger, K., Möller, H. J., Hampel, H., Davidsson, P. & Blennow, K., Sep 2003, In: Experimental Neurology. 183, 1, p. 74-80 7 p.

Treatment of aggressive behavior in dementia with the anticonvulsant topiramate: a retrospective pilot study

Fhager, B., Meiri, I-M., Sjögren, M. & Edman, A., Sep 2003, In: International Psychogeriatrics. 15, 3, p. 307-9 3 p.

The prevalence of frontal variant frontotemporal dementia and the frontal lobe syndrome in a population based sample of 85 year olds

Gislason, T. B., Sjögren, M., Larsson, L. & Skoog, I., Jul 2003, In: Journal of neurology, neurosurgery, and psychiatry. 74, 7, p. 867-71 5 p.

Advances in the detection of Alzheimer's disease-use of cerebrospinal fluid biomarkers

Sjögren, M., Andreasen, N. & Blennow, K., Jun 2003, In: Clinica chimica acta; international journal of clinical chemistry. 332, 1-2, p. 1-10 10 p.

Glycosylation of acetylcholinesterase and butyrylcholinesterase changes as a function of the duration of Alzheimer's disease

Sáez-Valero, J., Fodero, L. R., Sjögren, M., Andreasen, N., Amici, S., Gallai, V., Vanderstichele, H., Vanmechelen, E., Parnetti, L., Blennow, K. & Small, D. H., 15 May 2003, In: Journal of Neuroscience Research. 72, 4, p. 520-6 7 p.

Selective reduction of soluble Tau proteins in sporadic and familial frontotemporal dementias: An international follow-up study

Zhukareva, V., Sundarraj, S., Mann, D., Sjogren, M., Blenow, K., Clark, C. M., McKeel, D. W., Goate, A., Lippa, C. F., Vonsattel, J. P., Growdon, J. H., Trojanowski, J. Q. & Lee, V. M. Y., 1 May 2003, In: Acta Neuropathologica. 105, 5, p. 469-476 8 p.

Increased frequency of a new polymorphism in the cell division cycle 2 (cdc2) gene in patients with Alzheimer's disease and frontotemporal dementia

Johansson, A., Hampel, H., Faltraco, F., Buerger, K., Minthon, L., Bogdanovic, N., Sjögren, M., Zetterberg, H., Forsell, L., Lilius, L., Wahlund, L. O., Rymo, L., Prince, J. A. & Blennow, K., 3 Apr 2003, In: Neuroscience Letters. 340, 1, p. 69-73 5 p.

Altered levels of cerebrospinal fluid reelin in frontotemporal dementia and Alzheimer's disease

Sáez-Valero, J., Costell, M., Sjögren, M., Andreasen, N., Blennow, K. & Luque, J. M., 1 Apr 2003, In: Journal of Neuroscience Research. 72, 1, p. 132-6 5 p.

Lifetime burden of mood swings and activation of brain norepinephrine turnover in patients with treatment-refractory depressive illness

Ehnvall, A., Sjögren, M., Zachrisson, O. C. G. & Agren, H., Apr 2003, In: Journal of Affective Disorders. 74, 2, p. 185-9 5 p.

Biopsi av olfaktorisk slemhinna -- ny diagnostisk metod vid Creutzfeldt-Jakobs sjukdom

Sjogren, M. & Blennow, K., 2003, In: Laekartidningen. 100, 30-31, p. 2431 1 p.

Classification and subtypes of vascular dementia

Wallin, A., Milos, V., Sjögren, M., Pantoni, L. & Erkinjuntti, T., 2003, In: International Psychogeriatrics. 15 Suppl 1, p. 27-37 11 p.

Decreased cerebrospinal fluid acetylcholinesterase in patients with subcortical ischemic vascular dementia

Wallin, A., Sjögren, M., Blennow, K. & Davidsson, P., 2003, In: Dementia and Geriatric Cognitive Disorders. 16, 4, p. 200-7 8 p.

Iqbal, K., see Gong, C.-X., 107 Iseki, E., see Marui, W., 185 Ishii, R., Dziewas, R., Chau, W., Sörös, P., Okamoto, H., Gunji, A., Pantev, C., Current source density distribution of sleep spindles in humans as found by synthetic aperture magnetometry, 25

Johansson, A., Hampel, H., Faltraco, F., Buerger, K., Minthon, L., Bogdanovic, N., Sjögren, M., Zetterberg, H., Forsell, L. & Lilius, L., 2003, In: Neuroscience Letters. 340, p. 248-251 4 p.

Neuroticism Increases Risk for First Lifetime Episodes of Depression in a Birth Cohort of 70 Year Olds Followed for 15 Years: The Göteborg Longitudinal Study

Duberstein, P., Pálsson, S., Sjögren, M., Waern, M. & Skoog, I., 2003, In: The Eleventh International Congress.

Objective measurement of the alertness level in dementia

Edman, A., Brunovsky, M., Sjögren, M., Wallin, A. & Matousek, M., 2003, In: Dementia and Geriatric Cognitive Disorders. 15, 4, p. 212-7 6 p.

Om frontala funktioner och behandling

Sjogren, M., 2003, In: Tänkvärt. 2

Treatment with simvastatin in patients with Alzheimer's disease lowers both alpha- and beta-cleaved amyloid precursor protein

Sjögren, M., Gustafsson, K., Syversen, S., Olsson, A., Edman, A., Davidsson, P., Wallin, A. & Blennow, K., 2003, In: Dementia and Geriatric Cognitive Disorders. 16, 1, p. 25-30 6 p.

Studies of the pathophysiological mechanisms in frontotemporal dementia by proteome analysis of CSF proteins

Davidsson, P., Sjögren, M., Andreasen, N., Lindbjer, M., Nilsson, C. L., Westman-Brinkmalm, A. & Blennow, K., 30 Dec 2002, In: Brain Research. 109, 1-2, p. 128-33 6 p.

Cognition-enhancing effect of vagus nerve stimulation in patients with Alzheimer's disease: a pilot study

Sjögren, M. J. C., Hellström, P. T. O., Jonsson, M. A. G., Runnerstam, M., Silander, H. C-S. & Ben-Menachem, E., Nov 2002, In: Journal of Clinical Psychiatry. 63, 11, p. 972-80 9 p.

Relationship between depressive symptomatology and the subcortical brain syndrome in dementia

Lind, K., Edman, A., Karlsson, I., Sjögren, M. & Wallin, A., Aug 2002, In: International Journal of Geriatric Psychiatry. 17, 8, p. 774-8 5 p.

Ny möjlig princip för diagnos av Creutzfeldt-Jakobs sjukdom

Sjögren, M. & Blennow, K., 23 May 2002, In: Lakartidningen. 99, 21, p. 2382-4 3 p.

Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients

Davidsson, P., Westman-Brinkmalm, A., Nilsson, C. L., Lindbjer, M., Paulson, L., Andreasen, N., Sjögren, M. & Blennow, K., 16 Apr 2002, In: NeuroReport. 13, 5, p. 611-5 5 p.

Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia

Tarkowski, E., Issa, R., Sjögren, M., Wallin, A., Blennow, K., Tarkowski, A. & Kumar, P., 24 Jan 2002, In: Neurobiology of Aging. 23, 2, p. 237-43 7 p.

Biological correlates of clinical subgroups of Alzheimer's disease

Sjögren, M., Wikkelsö, C., Ostling, S., Wallin, A. & Blennow, K., 2002, In: Dementia and Geriatric Cognitive Disorders. 14, 4, p. 191-7 7 p.

Cerebrospinal fluid findings in vascular cognitive impairment with special reference to subcortical

Sjögren, M., Wallin, A. & Blennow, K., 2002, In: Vascular Cognitive Impairment. p. 459 1 p.

Cerebrospinal fluid markers of neurodegenerative disorders with emphasis on Alzheimer's disease

Sjögren, M., 2002, In: Journal of Neurochemistry. 81, p. 73-73 1 p.

Classification and subtypes of vascular dementia

Wallin, A., Milos, V., Sjogren, M., Pantoni, L. & Erkinjuntti, T., 2002, Vascular Cognitive Impairment. Martin Dunitz Publishers, p. 27-42 16 p.

Comparative study of CSF tau protein phosphorylated at threonine 231, threonine 181 and serine 199 in the diagnosis of Alzheimer's disease

Hampel, H., Buerger, K., Teipel, SJ., Moeller, HJ., Zinkowski, R., DeBarnardis, J., Kerkman, D., McCulloch, C., Sjoegren, M. & Blennow, K., 2002, NEUROBIOLOGY OF AGING. Vol. 23. p. S381-S381

Decreased CSF-beta-amyloid 42 in Alzheimer's disease and amyotrophic lateral sclerosis may reflect mismetabolism of beta-amyloid induced by disparate mechanisms

Sjögren, M., Davidsson, P., Wallin, A., Granérus, A-K., Grundström, E., Askmark, H., Vanmechelen, E. & Blennow, K., 2002, In: Dementia and Geriatric Cognitive Disorders. 13, 2, p. 112-8 7 p.

Farmakologisk behandling av kognitiv störning vid Alzheimers sjukdom.

Arvidsson, B., Beerman, B., Sjogren, M. & al., E., 2002, Medical Product Agency.

HPA axis activation in patients with few versus multiple episodes of depression

Ehnvall, A., Sjögren, M., Zachrisson, OCG. & Ågren, H., 2002, In: European Psychiatry. 17, p. 130 1 p.

Neurochemical markers in the cerebrospinal fluid in frontotemporal dementia. Relation to other dementia disorders

Sjögren, M., 2002, In: European Psychiatry. 17, p. 132 1 p.

Subcortical vascular dementia: cerebrospinal fluid determinations

Sjögren, M., Jonsson, M. & Wallin, A., 2002, In: European Psychiatry. 17, p. 20 1 p.

Subcortical vascular dementia: introduction and clinical picture/diagnosis

Wallin, A., Jonsson, M. & Sjögren, M., 2002, In: European Psychiatry. 17, p. 19 1 p.

The pathophysiology of frontotemporal dementia—cytoskeleton abnormalities and autoimmunity

Sjögren, M., 2002, In: The Aging Brain. 2, p. 18-26 9 p.

Usefulness of CSF total tau, Abeta42 and phospho tau as biomarkers for Alzheimer’s disease

Blennow, K., Sjogren, M. & Andreasen, N., 2002, In: Neurobiology og Aging, "Conference Report from 8th Int Conference on Alzheimer’s disease and related disorders, Stockholm, 2002".

Low cerebrospinal fluid beta-amyloid 42 in patients with acute bacterial meningitis and normalization after treatment

Sjögren, M., Gisslén, M., Vanmechelen, E. & Blennow, K., 13 Nov 2001, In: Neuroscience Letters. 314, 1-2, p. 33-6 4 p.

Neurofilament protein in cerebrospinal fluid: a marker of white matter changes

Sjögren, M., Blomberg, M., Jonsson, M., Wahlund, L. O., Edman, A., Lind, K., Rosengren, L., Blennow, K. & Wallin, A., 1 Nov 2001, In: Journal of Neuroscience Research. 66, 3, p. 510-6 7 p.

Cerebrospinal fluid cytoskeleton proteins in patients with subcortical white-matter dementia

Wallin, A. & Sjögren, M., Nov 2001, In: Mechanisms of Ageing and Development. 122, 16, p. 1937-49 13 p.

Pathophysiological aspects of frontotemporal dementia--emphasis on cytoskeleton proteins and autoimmunity

Sjögren, M. & Wallin, A., Nov 2001, In: Mechanisms of Ageing and Development. 122, 16, p. 1923-35 13 p.

Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values

Sjögren, M., Vanderstichele, H., Agren, H., Zachrisson, O., Edsbagge, M., Wikkelsø, C., Skoog, I., Wallin, A., Wahlund, L. O., Marcusson, J., Nägga, K., Andreasen, N., Davidsson, P., Vanmechelen, E. & Blennow, K., Oct 2001, In: Clinical Chemistry. 47, 10, p. 1776-81 6 p.

EDRF transcripts and diagnosis of variant Creutzfeldt-Jakob disease

Sjögren, M., 30 Jun 2001, In: Lancet. 357, 9274, p. 2069-70 2 p.

A new rating scale for age-related white matter changes applicable to MRI and CT

Wahlund, L. O., Barkhof, F., Fazekas, F., Bronge, L., Augustin, M., Sjögren, M., Wallin, A., Ader, H., Leys, D., Pantoni, L., Pasquier, F., Erkinjuntti, T., Scheltens, P. & European Task Force on Age-Related White Matter Changes, Jun 2001, In: Stroke. 32, 6, p. 1318-22 5 p.

The exfoliation syndrome in cognitive impairment of cerebrovascular or Alzheimer's type

Linnér, E., Popovic, V., Gottfries, C. G., Jonsson, M., Sjögren, M. & Wallin, A., Jun 2001, In: Acta Ophthalmologica Scandinavica. 79, 3, p. 283-5 3 p.

The cerebrospinal fluid levels of tau, growth-associated protein-43 and soluble amyloid precursor protein correlate in Alzheimer's disease, reflecting a common pathophysiological process

Sjögren, M., Davidsson, P., Gottfries, J., Vanderstichele, H., Edman, A., Vanmechelen, E., Wallin, A. & Blennow, K., 15 May 2001, In: Dementia and Geriatric Cognitive Disorders. 12, 4, p. 257-64 8 p.

Both total and phosphorylated tau are increased in Alzheimer's disease

Sjögren, M., Davidsson, P., Tullberg, M., Minthon, L., Wallin, A., Wikkelso, C., Granérus, A. K., Vanderstichele, H., Vanmechelen, E. & Blennow, K., May 2001, In: Journal of neurology, neurosurgery, and psychiatry. 70, 5, p. 624-30 7 p.

Clinic-based cases with frontotemporal dementia show increased cerebrospinal fluid tau and high apolipoprotein E epsilon4 frequency, but no tau gene mutations

Fabre, S. F., Forsell, C., Viitanen, M., Sjögren, M., Wallin, A., Blennow, K., Blomberg, M., Andersen, C., Wahlund, L. O. & Lannfelt, L., Apr 2001, In: Experimental Neurology. 168, 2, p. 413-8 6 p.

Clinic-Based Cases with Frontotemporal Dementia Show Increased Cerebrospinal Fluid Tau and High Apolipoprotein E ɛ4 Frequency, but No Tau Gene Mutations

Froelich Fabre, S., Forsell, C., Viitanen, M., Sjögren, M., Wallin, A., Blennow, K., Blomberg, M., Andersen, C., Wahlund, L-O. & Lannfelt, L., 2001, In: Experimental Neurology. 168, 2, p. 413-418 6 p.

Frontotemporal demens - en av de vanligaste demensformerna. Kliniska fynd, epidemiologi och patofysiologiska aspekter.

Sjogren, M., 2001, In: Nordisk Geriatrik. 3, p. 39-45 7 p.

Tacrine and rate of progression in Alzheimer's disease--relation to ApoE allele genotype

Sjögren, M., Hesse, C., Basun, H., Köl, G., Thostrup, H., Kilander, L., Marcusson, J., Edman, A., Wallin, A., Karlsson, I., Troell, M., Wachtmaister, G., Ekdahl, A., Olofsson, H., Sandström, A., Andreasen, N., Minthon, L. & Blennow, K., 2001, In: Journal of neural transmission (Vienna, Austria : 1996). 108, 4, p. 451-8 8 p.

Frontotemporal dementia can be distinguished from Alzheimer's disease and subcortical white matter dementia by an anterior-to-posterior rCBF-SPET ratio

Sjögren, M., Gustafson, L., Wikkelsö, C. & Wallin, A., 15 Aug 2000, In: Dementia and Geriatric Cognitive Disorders. 11, 5, p. 275-85 11 p.

Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD

Sjögren, M., Rosengren, L., Minthon, L., Davidsson, P., Blennow, K. & Wallin, A., 23 May 2000, In: Neurology. 54, 10, p. 1960-4 5 p.

Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization

Vanmechelen, E., Vanderstichele, H., Davidsson, P., Van Kerschaver, E., Van Der Perre, B., Sjögren, M., Andreasen, N. & Blennow, K., 5 May 2000, In: Neuroscience Letters. 285, 1, p. 49-52 4 p.

Oral d-fenfluramine test in treatment-refractory depression. Plasma prolactin response compared in patients with and without suicide attempts and in a healthy reference group

Prochazka, H., Sjögren, M. & Agren, H., 10 Mar 2000, In: Journal of Affective Disorders. 57, 1-3, p. 201-8 8 p.

CSF levels of tau, beta-amyloid(1-42) and GAP-43 in frontotemporal dementia, other types of dementia and normal aging

Sjögren, M., Minthon, L., Davidsson, P., Granérus A-K, Clarberg, A., Vanderstichele, H., Vanmechelen, E., Wallin, A. & Blennow, K., 2000, In: Journal of neural transmission (Vienna, Austria : 1996). 107, 5, p. 563-79 17 p.

Frontotemporal dementia-Clinical and pathophysiological aspects

Sjögren, M., 2000, In: Nordic Journal of Psychiatry. 54, 2, p. 149-150 2 p.

Symptoms, vascular risk factors and blood-brain barrier function in relation to CT white-matter changes in dementia

Wallin, A., Sjögren, M., Edman, A., Blennow, K. & Regland, B., 2000, In: European Neurology. 44, 4, p. 229-35 7 p.

Exekutiva funktioner och serotoninaktivitet hos deprimerade patienter. Samband speglar serotoninets inflytande på prefrontala kortex

Degl'Innocenti, A., Agren, H., Sjögren, M., Zachrisson, O. & Bäckman, L., 10 Nov 1999, In: Lakartidningen. 96, 45, p. 4918-9 2 p.

Neurofilament protein levels in CSF are increased in dementia

Rosengren, L. E., Karlsson, J. E., Sjögren, M., Blennow, K. & Wallin, A., 23 Mar 1999, In: Neurology. 52, 5, p. 1090-3 4 p.

Decreased monoamine metabolites in frontotemporal dementia and Alzheimer's disease

Sjögren, M., Minthon, L., Passant, U., Blennow, K. & Wallin, A., 8 Jan 1999, In: Neurobiology of Aging. 19, 5, p. 379-84 6 p.

Frontotemporal dementia. Clinical and pathophysiological aspects

Sjögren, M., 1999

Subcortical Symptomatology, Vascular Disease of Non-Stroke Type and Blood-Brain Barrier Dysfunction are Related to Radiological White-Matter Changes in Dementia

Wallin, A., Sjoegren, M., Edman, A., Blennow, K. & Regland, B., 1999, In: ALZHEIMERS REPORTS. 2, p. 76-76 1 p.

Longitudinal EEG findings in dementia related to the parietal brain syndrome and the degree of dementia

Edman, A., Matousek, M., Sjögren, M. & Wallin, A., 29 Jul 1998, In: Dementia and Geriatric Cognitive Disorders. 9, 4, p. 199-204 6 p.

Symptomatological characteristics distinguish between frontotemporal dementia and vascular dementia with a dominant frontal lobe syndrome

Sjögren, M., Wallin, A. & Edman, A., Jun 1997, In: International Journal of Geriatric Psychiatry. 12, 6, p. 656-61 6 p.

The apolipoprotein E epsilon4 allele frequency is normal in fronto-temporal dementia, but correlates with age at onset of disease

Minthon, L., Hesse, C., Sjögren, M., Englund, E., Gustafson, L. & Blennow, K., 18 Apr 1997, In: Neuroscience Letters. 226, 1, p. 65-7 3 p.

Stepwise comparative status analysis (STEP): a tool for identification of regional brain syndromes in dementia

Wallin, A., Edman, A., Blennow, K., Gottfries, C. G., Karlsson, I., Regland, B. & Sjögren, M., Oct 1996, In: Journal of Geriatric Psychiatry and Neurology. 9, 4, p. 185-99 15 p.

Neurochemical and treatment studies on frontotemporal dementia

Sjogren, M., Blennow, K., Minthon, L. & al., E., 1996, Frontotemporal Dementia. ICG Publications, Vol. 8. p. 91-98 8 p.

Cerebrospinal fluid neuropeptides in Alzheimer's disease and vascular dementia

Heilig, M., Sjögren, M., Blennow, K., Ekman, R. & Wallin, A., 15 Aug 1995, In: Biological Psychiatry. 38, 4, p. 210-6 7 p.

Cytosolic free calcium elevation mediates the phagosome-lysosome fusion during phagocytosis in human neutrophils

Jaconi, M. E., Lew, D. P., Carpentier, J. L., Magnusson, K. E., Sjögren, M. & Stendahl, O., May 1990, In: Journal of Cell Biology. 110, 5, p. 1555-64 10 p.

Activities

Video on Treatment of eating disorders

Jan Magnus Sjögren (Other)

19 Aug 2020

21-årig dansker lider af inbildt grimhed

Jan Magnus Sjögren (Lecturer)

26 Dec 2018

Videnskabelig podcast om reernæringssyndrom (RFS)

Jan Magnus Sjögren (Lecturer)

26 Nov 2018

Forsker: 'Jo længere man har haft anoreksi, jo sværere er det at komme sig helt’

Jan Magnus Sjögren (Participant)

4 Nov 2018

Dysmorfofobi: Besat af sit eget spejlbillede

Jan Magnus Sjögren (Lecturer)

17 Sep 2018

36-årig anorektiker om billeder af sig selv

Jan Magnus Sjögren (Lecturer)

3 May 2017

Presentation at Danske Regioners meeting on Eating Disorders

Jan Magnus Sjögren (Lecturer)

27 Oct 2016

Projects

Anoreksi: Hvorfor fravælger halvdelen behandling?

Sjögren, J. M., Thor_Andersen, S. & Gildberg, F.

01/01/201831/10/2022

A study of the effects of GLP-2

Sjögren, J. M., Feltoft, C. L., Madsbad, S. & Rosenkilde, M. M.

01/02/2020 → …

Bachelor- og specialestuderende ved Forskningsenhed for Spiseforstyrrelser

Sjögren, J. M.

01/01/201731/12/2024

Biology of the Refeeding Syndrom in Eating Disorders

Sjögren, J. M., Feltoft, C. L. & Pauli Sonne, M.

07/10/2020 → …

Comprehensive Risk Evaluation for Anorexia nervosa in Twins

Sjögren, J. M., Rask, L., Hasselbalch , K. C. & Vangsgaard Rosager, E.

02/04/201930/04/2022

Funen Anorexia Nervosa Study - a follow-up study on outcome, mortality, quality of life and body composition

Sjögren, J. M. & Støving, R.

01/07/201531/01/2023

Inflammation and Neuroprogression in Anorexia Nervosa (underprojekt til PROLED)

Sjögren, J. M., Rasmussen Lanng, K. & Gillum, M.

01/08/201801/08/2021

Lighting Metropolis

Sjögren, J. M., Mullins, M. & Triantifyllidis, G.

01/01/201831/08/2020

Lipid alterations in patients with anorexia nervosa (LIAN)

Sjögren, J. M. & Hussain, A.

01/01/201829/01/2023

PROLED - PROspective Longitudinal all comer inclusion study on Eating Disorders

Sjögren, J. M., Hussain, A., Rask, L., Rasmussen Lanng, K. & Lokind, T.

11/01/201631/12/2026

Systematiske reviews indenfor spiseforstyrrelser

Sjögren, J. M.

01/01/201829/02/2028

The acquisition of body image – exploring the psychological experience of embodiment and mentalization in anorexia nervosa

Sjögren, J. M. & Katznelson, H.

01/10/201801/10/2021

ID: 49125643